Menu

House Democrats Introduce “Scientific Integrity Act”

Representatives follow the lead of senators in drafting a bill that would encourage federal scientists to share data.

Mar 3, 2017
Kerry Grens

WIKIPEDIA, O.J.On Thursday (March 2), democrats in the US House of Representatives introduced a bill aimed at securing an open exchange of data among federal scientists, their colleagues, and the public. Senate democrats introduced similar legislation in February, which they called the Scientific Integrity Act.

“I am concerned about the increasing suppression or denial of widely supported and tested scientific findings by some government and private sector leaders because of politics, ideology, or financial conflicts of interest,” Eddie Bernice Johnson (D-TX), a member of the House Science Committee and a bill cosponsor, said in a press release. “Those actions have contributed to an erosion in the public’s trust in science and done great harm to policymakers’ ability to develop smart solutions to our nation’s challenges.”

The bill would require the director of the Office of Science and Technology Policy to draft policy supporting an “open exchange of data and findings” and preventing “the suppression or distortion of the data or findings.” It also asks the heads of agencies that fund science to institute policies that prevent political intervention in practicing science, disseminating results, and making personnel decisions.

Science advocates have recently been concerned that certain agencies, including the Environmental Protection Agency, might be subject to gag orders (a claim disputed by the Trump administration). “If ever there was a time that such a bill is needed, it is now,” Gretchen Goldman of the Union of Concerned Scientists told ScienceInsider in February.

See “Science Policy in 2017

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!